{
    "organizations": [],
    "uuid": "9cc663345458e17e1eee2ba7d88cfd273d570aab",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/03/06/the-associated-press-adverum-biotechnologies-posts-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Adverum Biotechnologies posts 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "MENLO PARK, Calif. (AP) _ Adverum Biotechnologies Inc. (ADVM) on Tuesday reported a loss of $14.8 million in its fourth quarter.\nOn a per-share basis, the Menlo Park, California-based company said it had a loss of 32 cents.\nThe results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share.\nThe gene therapy company posted revenue of $461,000 in the period.\nFor the year, the company reported that its loss narrowed to $56.1 million, or $1.29 per share. Revenue was reported as $1.8 million.\nAdverum Biotechnologies shares have more than doubled since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $7.20, more than doubling in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on ADVM at https://www.zacks.com/ap/ADVM",
    "published": "2018-03-07T02:15:00.000+02:00",
    "crawled": "2018-03-07T13:50:27.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "menlo",
        "park",
        "ap",
        "adverum",
        "biotechnology",
        "advm",
        "tuesday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "basis",
        "menlo",
        "park",
        "company",
        "said",
        "loss",
        "cent",
        "result",
        "surpassed",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "three",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "loss",
        "cent",
        "per",
        "share",
        "gene",
        "therapy",
        "company",
        "posted",
        "revenue",
        "period",
        "year",
        "company",
        "reported",
        "loss",
        "narrowed",
        "million",
        "per",
        "share",
        "revenue",
        "reported",
        "million",
        "adverum",
        "biotechnology",
        "share",
        "doubled",
        "since",
        "beginning",
        "year",
        "final",
        "minute",
        "trading",
        "tuesday",
        "share",
        "hit",
        "doubling",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "advm",
        "http"
    ]
}